Singapore - Tandem Diabetes Care, a medical device company and manufacturer of the only touchscreen insulin pumps availa...
MTPConnect and the Minister for Health, the Hon Greg Hunt MP, recently announced that Indee Labs will be receiving grant...
Australia based SpeeDx has announced a distribution agreement with Serosep Ltd, a leading manufacturer and distributor o...
Cancer Australia has launched a Framework to improve the outcomes and experiences of people affected by lung cancer &nda...
Singapore – Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development o...
A team of researchers at the University of Adelaide has invented a world-first tiny fibre-optic probe that can simultane...
Outgoing CEO of the Generic and Biosimilar Medicines Association (GBMA), Belinda Wood has been appointed to the role of ...
Researchers at the University of New South Wales (UNSW) in Sydney, Australia, have used CRISPR gene editing technology t...
Cellmid Limited announced that it has entered into an agreement with Labo International S.r.l to undertake the exclusive...
Indian biotech major Biocon said that the biosimilar insulin glargine co-developed with US drug major partner Mylan rece...
Australia's Mayne Pharma Group recently announced the launch of doxycycline monohydrate immediate release (IR...
Propanc Biopharma Inc., a clinical stage biopharmaceutical company focusing on development of new and proprietary treatm...
The Australian Council on Healthcare Standards (ACHS), Australia's leading independent authority on healthcare, has reco...
Australia’s biotech giant Immutep has announced that it has entered into a clinical trial collaboration and supply...
Phase I clinical trials to assess its safety, human tolerance, and pharmacokinetic properties. XW10172 is the first comp...
A team of scientists from the Walter and Eliza Hall Institute of Medical Research in Australia have discovered a unique ...
Globally, the radiopharmaceutical medicine market is expected to reach USD 13.8 billion by 2024, according to a new repo...
In a bid to further broaden its immune-oncology portfolio, Merck has recently acquired Australian firm Viralytics ...
